Skip to content

house · Committee report

H. Rept. 118-891

PRESERVING TELEHEALTH, HOSPITAL, AND AMBULANCE ACCESS ACT

2024-12-17

Committees

Associated legislation

Text

Background

H.R. 8261 was introduced on May 8, 2024, and was referred to the Committee on Ways and Means and the Committee on Energy and Commerce. Committee Hearings The Committee on Ways and Means held the following hearing concerning the policy in H.R. 8261: On Tuesday, March 12, 2024, the Committee on Ways and Means held a hearing titled, ``Enhancing Access to Care at Home in Rural and Underserved Communities'' to explore how telehealth flexibilities have allowed for care delivery innovations that particularly help hard-to-reach patients.

Committee Action

The Committee on Ways and Means marked up H.R. 8261, the ``Preserving Telehealth, Hospital, and Ambulance Access Act'' on May 8, 2024, and favorably reported the bill, as amended, to the House of Representatives (with quorum being present). D. Designated Hearing Pursuant to clause 3(c)(6) of rule XIII, the following hearing was used to develop and consider H.R. 8261: On Tuesday, March 12, 2024, the Committee on Ways and Means held a hearing titled, ``Enhancing Access to Care at Home in Rural and Underserved Communities.'' II. EXPLANATION OF THE BILL A. Reasons for Change The Consolidated Appropriations Act of 2023 extended Medicare telehealth flexibilities, ambulance add-on payments, and the Acute Hospital at Home Program, through December 31, 2024. The MDH designation and enhanced LVA eligibility will both expire after December 31, 2024, absent congressional action. Under current law, PDPs and MA-PDs are not permitted to collect rebates that are based on the list price of a prescription drug. With current authority, CMS is limited in their ability to monitor PDP and MA-PD rebating practices and enforce prohibition of certain rebating practices on such entities. B. Explanation of Provisions With respect to Medicare telehealth services, this policy amends section 1834(m) of the Social Security Act by extending the following telehealth flexibilities for two years through December 31, 2026. Removing geographic restrictions and expanding originating sites. Expanding practitioners able to bill Medicare for telehealth services to include physical therapists, occupational therapists, audiologists and speech language pathologists. Allowing Federally Qualified Health Centers and Rural Health Clinics to bill Medicare for telehealth services. Delaying the in-person visit requirements for mental health telehealth eligibility. Allowing reimbursement for certain services to be provided via audio-only telehealth visits. Allowing hospice providers (except for hospices in areas with moratoria or hospices in the provisional period of enhanced oversight for new providers) to use telehealth to conduct the face-to-face visit required for hospice recertification. Telehealth (me) This policy extends the waivers that comprise the Acute Hospital at Home Program through 2029 and requires an additional report on the Program's status no later than September 30, 2028. The policy extends the MDH Program and the enhanced LVA eligibility until October 1, 2025. With respect to the Medicare ambulance add-on payments, this policy amends section 1834(l) of the Social Security Act to extend the three add-on payments under the Medicare ambulance fee schedule through September 30, 2025. The urban add-on payment will continue to provide a 2 percent increase in both the base payment and the mileage rate under the fee schedule. The rural add-on payment will continue to provide a 3 percent increase in both the base payment and the mileage rate under the fee schedule. The super-rural add-on payment will continue to provide a 22.6 percent increase in the base payment, in addition to the 3 percent increase in the mileage rate that applies to rural areas as a part of the rural add-on payment. Beginning in 2027, any PDP or MA-PD plan that contracts with a PBM must meet the requirements outlined below. PBMs will be required to use Bona Fide Service fees, a flat dollar amount that is charged per item. Bona Fide Service Fees are not allowed to be based off of a drug's price or other variable factors. PBMs will have new transparency standards for contracts with PDPs and will be required to report the below data to the Department of Health and Human Services: Lists of all drugs covered; Information about dispensing of such drugs; Information about enrollee cost-sharing and access to generics and biosimilars if plans cover the brand-name drugs or biologic reference products; Information on other financial relationships between the PBM and other entities in the drug pricing supply chain; Information related to net and gross prices and total drug spending; and Information about the PBM's affiliates. C. Effective Date The bill would become effective upon enactment. III. VOTES OF THE COMMITTEE In compliance with the Rules of the House of Representatives, the following statement is made concerning the vote of the Committee on Ways and Means during the markup consideration of H.R. 8261, the ``Preserving Telehealth, Hospital, and Ambulance Access Act''. The vote on the amendment offered by Mr. Doggett to the amendment in the nature of a substitute to H.R. 8261, which would require prepayment review of Medicare billing claims for certain durable medical equipment and clinical diagnostic laboratory tests at high risk of fraud when such claims have aberrant billing patterns was not agreed to by a roll call vote of 17 yeas to 23 nays (with a quorum being present). The vote was as follows: ---------------------------------------------------------------------------------------------------------------- Representative Yea Nay Present Representative Yea Nay Present ---------------------------------------------------------------------------------------------------------------- Mr. Smith (MO)................ ........ X ......... Mr. Neal........ X ......... ......... Mr. Buchanan.................. ........ X ......... Mr. Doggett..... X ......... ......... Mr. Smith (NE)................ ........ X ......... Mr. Thompson.... X ......... ......... Mr. Kelly..................... ........ X ......... Mr. Larson...... ........ ......... ......... Mr. Schweikert................ ........ X ......... Mr. Blumenauer.. X ......... ......... Mr. LaHood.................... ........ X ......... Mr. Pascrell.... X ......... ......... Dr. Wenstrup.................. ........ X ......... Mr. Davis....... X ......... ......... Mr. Arrington................. ........ ......... ......... Ms. Sanchez..... X ......... ......... Dr. Ferguson.................. ........ X ......... Ms. Sewell...... X ......... ......... Mr. Estes..................... ........ X ......... Ms. DelBene..... X ......... ......... Mr. Smucker................... ........ X ......... Ms. Chu......... X ......... ......... Mr. Hern...................... ........ ......... ......... Ms. Moore....... X ......... ......... Ms. Miller.................... ........ X ......... Mr. Kildee...... X ......... ......... Dr. Murphy.................... ........ X ......... Mr. Beyer....... X ......... ......... Mr. Kustoff................... ........ X ......... Mr. Evans....... X ......... ......... Mr. Fitzpatrick............... ........ X ......... Mr. Schneider... X ......... ......... Mr. Steube.................... ........ X ......... Mr. Panetta..... X ......... ......... Ms. Tenney.................... ........ X ......... Mr. Gomez....... X ......... ......... Mrs. Fischbach................ ........ X ......... Mr. Moore..................... ........ X ......... Mrs. Steel.................... ........ X ......... Ms. Van Duyne................. ........ X ......... Mr. Feenstra.................. ........ X ......... Ms. Malliotakis............... ........ X ......... Mr. Carey..................... ........ X ......... ---------------------------------------------------------------------------------------------------------------- VOTES OF THE COMMITTEE In compliance with the Rules of the House of Representatives, the following statement is made concerning the vote of the Committee on Ways and Means during the markup consideration of H.R. 8261, the ``Preserving Telehealth, Hospital, and Ambulance Access Act,'' on May 8, 2024. The vote on the amendment offered by Ms. Sewell to the amendment in the nature of a substitute to H.R. 8261, which would extend the ground ambulance, low volume, and Medicare dependent hospitals for two years was not agreed to by a roll call vote of 17 yeas to 23 nays (with a quorum being present). The vote was as follows: ---------------------------------------------------------------------------------------------------------------- Representative Yea Nay Present Representative Yea Nay Present ---------------------------------------------------------------------------------------------------------------- Mr. Smith (MO)................ ........ X ......... Mr. Neal........ X ......... ......... Mr. Buchanan.................. ........ X ......... Mr. Doggett..... ........ ......... ......... Mr. Smith (NE)................ ........ X ......... Mr. Thompson.... X ......... ......... Mr. Kelly..................... ........ X ......... Mr. Larson...... X ......... ......... Mr. Schweikert................ ........ X ......... Mr. Blumenauer.. X ......... ......... Mr. LaHood.................... ........ X ......... Mr. Pascrell.... X ......... ......... Dr. Wenstrup.................. ........ X ......... Mr. Davis....... X ......... ......... Mr. Arrington................. ........ ......... ......... Ms. Sanchez..... X ......... ......... Dr. Ferguson.................. ........ X ......... Ms. Sewell...... X ......... ......... Mr. Estes..................... ........ X ......... Ms. DelBene..... X ......... ......... Mr. Smucker................... ........ X ......... Ms. Chu......... X ......... ......... Mr. Hern...................... ........ ......... ......... Ms. Moore....... X ......... ......... Ms. Miller.................... ........ X ......... Mr. Kildee...... X ......... ......... Dr. Murphy.................... ........ X ......... Mr. Beyer....... X ......... ......... Mr. Kustoff................... ........ X ......... Mr. Evans....... X ......... ......... Mr. Fitzpatrick............... ........ X ......... Mr. Schneider... X ......... ......... Mr. Steube.................... ........ X ......... Mr. Panetta..... X ......... ......... Ms. Tenney.................... ........ X ......... Mr. Gomez....... X ......... ......... Mrs. Fischbach................ ........ X ......... Mr. Moore..................... ........ X ......... Mrs. Steel.................... ........ X ......... Ms. Van Duyne................. ........ X ......... Mr. Feenstra.................. ........ X ......... Ms. Malliotakis............... ........ X ......... Mr. Carey..................... ........ X ......... ---------------------------------------------------------------------------------------------------------------- VOTES OF THE COMMITTEE In compliance with the Rules of the House of Representatives, the following statement is made concerning the vote of the Committee on Ways and Means during the markup consideration of H.R. 8261, the ``Preserving Telehealth, Hospital, and Ambulance Access Act,'' on May 8, 2024. H.R. 8261 was ordered favorably reported to the House of Representatives as amended by a roll call vote of 41 yeas to 0 nays (with a quorum being present). The vote was as follows: ---------------------------------------------------------------------------------------------------------------- Representative Yea Nay Present Representative Yea Nay Present ---------------------------------------------------------------------------------------------------------------- Mr. Smith (MO)................ X ......... ......... Mr. Neal........ X ......... ......... Mr. Buchanan.................. X ......... ......... Mr. Doggett..... X ......... ......... Mr. Smith (NE)................ X ......... ......... Mr. Thompson.... X ......... ......... Mr. Kelly..................... X ......... ......... Mr. Larson...... X ......... ......... Mr. Schweikert................ X ......... ......... Mr. Blumenauer.. X ......... ......... Mr. LaHood.................... X ......... ......... Mr. Pascrell.... X ......... ......... Dr. Wenstrup.................. X ......... ......... Mr. Davis....... X ......... ......... Mr. Arrington................. ........ ......... ......... Ms. Sanchez..... X ......... ......... Dr. Ferguson.................. X ......... ......... Ms. Sewell...... X ......... ......... Mr. Estes..................... X ......... ......... Ms. DelBene..... X ......... ......... Mr. Smucker................... X ......... ......... Ms. Chu......... X ......... ......... Mr. Hern...................... ........ ......... ......... Ms. Moore....... X ......... ......... Ms. Miller.................... X ......... ......... Mr. Kildee...... X ......... ......... Dr. Murphy.................... X ......... ......... Mr. Beyer....... X ......... ......... Mr. Kustoff................... X ......... ......... Mr. Evans....... X ......... ......... Mr. Fitzpatrick............... X ......... ......... Mr. Schneider... X ......... ......... Mr. Steube.................... X ......... ......... Mr. Panetta..... X ......... ......... Ms. Tenney.................... X ......... ......... Mr. Gomez....... X ......... ......... Mrs. Fischbach................ X ......... ......... Mr. Moore..................... X ......... ......... Mrs. Steel.................... X ......... ......... Ms. Van Duyne................. X ......... ......... Mr. Feenstra.................. X ......... ......... Ms. Malliotakis............... X ......... ......... Mr. Carey..................... X ......... ......... ---------------------------------------------------------------------------------------------------------------- IV. BUDGET EFFECTS OF THE BILL A. Committee Estimate of Budgetary Effects With respect to clause 3(d) of rule XIII of the Rules of the House of Representatives, a cost estimate provided by the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not made available to the Committee in time for the filing of this report. B. Statement Regarding New Budget Authority and Tax Expenditures Budget Authority In compliance with clause 3(c)(2) of rule XIII of the Rules of the House of Representatives, the Committee states that the bill involved no new or increased budget authority. The Committee states further that the bill involves no new or increased tax expenditures. C. Cost Estimate Prepared by the Congressional Budget Office With respect to the requirements of clause 3(c)(2) of rule XIII of the Rules of the House of Representatives and section 308(a) of the Congressional Budget Act of 1974 and with respect to requirements of clause (3)(c)(3) of rule XIII of the Rules of the House of Representatives and section 402 of the Congressional Budget Act of 1974, the Committee has requested but not received a cost estimate for this bill from the Director of Congressional Budget Office. The Chairman of the Committee shall cause such estimate and statement to be printed in the Congressional Record upon its receipt by the Committee. V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE A. Committee Oversight Findings and Recommendations With respect to clause 3(c)(1) of rule XIII of the Rules of the House of Representatives, the Committee made findings and recommendations that are reflected in this report. B. Statement of General Performance Goals and Objectives With respect to clause 3(c)(4) of rule XIII of the Rules of the House of Representatives, the Committee advises that the bill does not authority funding, so no statement of general performance goals and objectives is required. C. Information Relating to Unfunded Mandates This information is provided in accordance with section 423 of the Unfunded Mandates Reform Act of 1995 (Pub. L. No. 104- 4). The Committee has determined that the bill does not contain Federal mandates on the private sector. The Committee has determined that the bill does not impose a Federal intergovernmental mandate on State, local, or tribal governments. D. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff Benefits With respect to clause 9 of rule XXI of the Rules of the House of Representatives, the Committee has carefully reviewed the provisions of the bill, and states that the provisions of the bill do not contain any congressional earmarks, limited tax benefits, or limited tariff benefits within the meaning of the rule. E. Duplication of Federal Programs In compliance with clause 3(c)(5) of rule XIII of the Rules of the House of Representatives, the Committee states that no provision of the bill establishes or reauthorizes: (1) a program of the Federal Government known to be duplicative of another Federal program; (2) a program included in any report from the Government Accountability Office to Congress pursuant to section 21 of Public Law 111-139; or (3) a program related to a program identified in the most recent Catalog of Federal Domestic Assistance, published pursuant to the Federal Program Information Act (Pub. L. No. 95-220, as amended by Pub. L. No. 98-169). VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): SOCIAL SECURITY ACT * * * * * * * TITLE XVIII--HEALTH INSURANCE FOR THE AGED AND DISABLED * * * * * * * Part A--Hospital Insurance Benefits for the Aged and Disabled * * * * *

Source: https://api.congress.gov/v3/committee-report/118/hrpt/891